These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3625198)

  • 1. Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning.
    Malas KL; van Kammen DP; de Fraites EA; Brown GM; Gold PW
    J Neural Transm; 1987; 69(3-4):319-24. PubMed ID: 3625198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine.
    Whalley LJ; Christie JE; Brown S; Arbuthnott GW
    Arch Gen Psychiatry; 1984 Nov; 41(11):1040-3. PubMed ID: 6497565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients.
    Zemlan FP; Hirschowitz J; Garver DL
    Arch Gen Psychiatry; 1986 Dec; 43(12):1162-7. PubMed ID: 3778112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic and dopaminergic interrelation in schizophrenia.
    Brambilla F; Marini S; Saito A; Fassone G; Picardi A; Nerozzi D; Pancheri P
    Psychiatry Res; 1994 Sep; 53(3):231-42. PubMed ID: 7870845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postsynaptic supersensitivity in schizophrenia.
    Pandey GN; Garver DL; Tamminga C; Ericksen S; Ali SI; Davis JM
    Am J Psychiatry; 1977 May; 134(5):518-22. PubMed ID: 848578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone responses to apomorphine HCl in schizophrenic patients on drug holidays and at relapse.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Dermer SW; MacCrimmon DJ; Mitton J
    Br J Psychiatry; 1983 May; 142():482-8. PubMed ID: 6135481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal instability of hormone responses in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):545-9. PubMed ID: 6686692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to clozapine.
    Lieberman JA; Kane JM; Safferman AZ; Pollack S; Howard A; Szymanski S; Masiar SJ; Kronig MH; Cooper T; Novacenko H
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():126-8. PubMed ID: 7961556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone response to growth hormone releasing hormone in depression and schizophrenia.
    Peabody CA; Warner MD; Markoff E; Hoffman AR; Wilson DM; Csernansky JG
    Psychiatry Res; 1990 Sep; 33(3):269-76. PubMed ID: 2243902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine.
    Zemlan FP; Hirschowitz J; Sautter F; Garver DL
    Psychiatry Res; 1986 Jul; 18(3):239-55. PubMed ID: 2875478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal growth hormone studies in schizophrenia.
    Brown GM; Cleghorn JM; Kaplan RD; Szechtman H; Brown PJ; Szechtman B; Mitton J
    Psychiatry Res; 1988 May; 24(2):123-36. PubMed ID: 3406233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
    Kolakowska T; Gelder M; Fraser S
    Br J Psychiatry; 1981 Nov; 139():408-12. PubMed ID: 6120733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
    Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K
    Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multihormonal responses to apomorphine in mental illness.
    Mokrani MC; Duval F; Crocq MA; Bailey PE; Macher JP
    Psychoneuroendocrinology; 1995; 20(4):365-75. PubMed ID: 8532820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning.
    Mueser KT; Bellack AS; Morrison RL; Wixted JT
    J Psychiatr Res; 1990; 24(1):51-63. PubMed ID: 2366213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response.
    Meltzer HY; Perline R; Lewine R
    J Nerv Ment Dis; 1982 Dec; 170(12):758-65. PubMed ID: 6754871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.